by webmaster | Jun 23, 2026 | Generic & Biosimilar Insights
Healthcare systems globally continue to face increasing pressure from rising treatment demand, constrained healthcare budgets and growing chronic disease burdens. In South Africa, these challenges exist alongside the need to expand access to essential medicines across...
by webmaster | Jun 15, 2026 | Generic & Biosimilar Insights
As winter approaches in South Africa, healthcare systems typically experience a noticeable increase in demand for medicines linked to seasonal illness. Respiratory infections, influenza, asthma complications, and secondary bacterial infections often rise during colder...
by webmaster | Jun 4, 2026 | Generic & Biosimilar Insights
Pharmacists play a central role in how medicines are used at the point of care, particularly in the adoption of generics and biosimilars. While regulatory authorities ensure that these medicines meet established standards for quality, safety, and efficacy, their...
by webmaster | May 27, 2026 | Generic & Biosimilar Insights
Confidence in medicines is built over time through consistent quality, reliable supply, and adherence to well-defined standards. In South Africa, manufacturers represented within the generics, biosimilars, and medicines sector operate within a structured regulatory...
by webmaster | May 14, 2026 | Generic & Biosimilar Insights
The quality and effectiveness of many medicines depend not only on how they are manufactured, but also on how they are stored and transported throughout the supply chain. Temperature-sensitive products such as vaccines, insulin, and biologic therapies require strict...
by webmaster | May 6, 2026 | Generic & Biosimilar Insights
The availability of medicines at facility level is the result of a structured process that spans multiple stages, from regulatory approval through to final dispensing. Each step in this pathway is governed by defined systems and responsibilities, and the interaction...
